Bird & Bird advised Health-Tech-VC on EUR 1.3 million investment in RYVER.AI

Contacts

andrea schlote Module
Andrea Schlote

Counsel
Germany

As a Counsel in our Corporate / M&A Team in Munich, I focus on domestic and international venture capital and venture lending transactions for emerging and high-growth companies.

The international law firm Bird & Bird has advised the Spanish health-tech venture capital firm, Nina Capital, on its investment in the Munich-based health-tech startup, RYVER.AI.

Nina Capital led the financing round, other investors include Bayern Kapital (Germany) and FundF (Austria). The capital will primarily be used for technical development, personnel and computing capacity. RYVER.AI develops generative models that enable medical AI providers to generate a wide range of test and training data quickly and cost-effectively. The start-up aims to solve the data shortage for medical AI without jeopardizing patient privacy. The company develops generative AI to create artificial but highly realistic datasets of radiological images.

Nina Capital was advised by the following Bird & Bird lawyers: counsel Andrea Schlote (lead), Partner Stefan Münch, counsel Dr. Christina Lorenz, associate Louisa Graf (all Corporate/M&A, Munich), Partner Martin von Haller Grønbæk (Commercial, Copenhagen) and associate Yvonne Schaafs (IP, Munich).


News & Deals

More News & Deals

News

Bird & Bird maintains Mansfield Certification for the third year

Oct 04 2024

Read More

Deal

Bird & Bird advises T. Tazaki & Company on the acquisition of Agrica

Oct 04 2024

Read More

News

Bird & Bird strengthens its team in Slovakia

Oct 02 2024

Read More

Deal

Bird & Bird advises GenIP on its AIM IPO

Oct 02 2024

Read More

Deal

Bird & Bird advised the lenders in Babcock Wanson Group’s refinancing, as well as Ambienta's acquisition

Sep 23 2024

Read More

News

Bird & Bird advises traxi on €1.5 million financing round

Sep 20 2024

Read More